Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2–4 and 10

被引：0
|
作者：
Matthew Capehorn
Yasmin Ghani
Charlotte Hindsberger
Pierre Johansen
Esteban Jódar
机构：
[1] Rotherham Institute for Obesity (RIO),
[2] Clifton Medical Centre,undefined
[3] Novo Nordisk A/S,undefined
[4] S-cubed APS (contracted by Novo Nordisk A/S),undefined
[5] Novo Nordisk A/S,undefined
[6] Hospital Universitario Quiron Salud Madrid,undefined
[7] Universidad Europea de Madrid,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Diabetes care; GLP-1RA; Metformin; Oral antidiabetic agents; Randomised controlled trials; Semaglutide; Sulphonylurea; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1061 / 1075
页数：14
相关论文
共 50 条
  • [31] Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study
    Serpa-Diaz, Dagoberto
    Llanos-Florez, Carlos A.
    Uribe, Ronald Serrano
    de Salazar, Dora I. Molina
    Giraldo-Gonzalez, German C.
    Urina-Triana, Miguel
    Suarez-Rodriguez, Andres F.
    Alzate-Vinasco, Maria A.
    DIABETES THERAPY, 2024, 15 (06) : 1451 - 1460
  • [32] Efficacy and safety of once-weekly semaglutide in elderly subjects with type 2 diabetes: post hoc analysis of SUSTAIN 1-5 trials
    Warren, M.
    Chaykin, L.
    Trachtenbarg, D.
    Nayak, G.
    Wijayasinghe, N.
    Cariou, B.
    DIABETOLOGIA, 2017, 60 : S378 - S379
  • [33] Managing Type 2 Diabetes: Balancing HbA1c and Body Weight
    Mavian, Annie A.
    Miller, Stephan
    Henry, Robert R.
    POSTGRADUATE MEDICINE, 2010, 122 (03) : 106 - 117
  • [34] Real-world HbA1c changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes
    Frazer, Monica
    Swift, Caroline
    Sargent, Andrew
    Leszko, Michael
    Buysman, Erin
    Gronroos, Noelle N.
    Alvarez, Sara
    Dunn, Tyler J.
    Noone, Josh
    Gamble, Cory L.
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (01) : 783 - 788
  • [35] Once-Weekly Semaglutide Versus Sodium-Glucose Co-transporter 2 Inhibitors: Real-World Impact on Weight, HbA1c, and Healthcare Resource Utilization in Type 2 Diabetes (PAUSE)
    James Amamoo
    Riddhi Doshi
    Joshua Noone
    Lin Xie
    Cory Gamble
    Mico Guevarra
    Victoria Divino
    Justin Chen
    Aaron King
    Diabetes Therapy, 2025, 16 (5) : 1033 - 1048
  • [36] Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post-hoc analysis
    Araki, Eiichi
    Harashima, Shinichi
    Nishida, Tomoyuki
    Nakamura, Jiro
    JOURNAL OF DIABETES INVESTIGATION, 2022, : 1971 - 1980
  • [37] The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis
    Anne Lautenbach
    Marie Wernecke
    Tobias B. Huber
    Fabian Stoll
    Jonas Wagner
    Sebastian M. Meyhöfer
    Svenja Meyhöfer
    Jens Aberle
    Obesity Surgery, 2022, 32 : 3280 - 3288
  • [38] Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis
    Kobo, Ofer
    Cavender, Matthew A.
    Jensen, Thomas Jon
    Kuhlman, Anja Birk
    Rasmussen, Soren
    Verma, Subodh
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 1129 - 1132
  • [39] The Potential of Semaglutide Once-Weekly in Patients without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss after Bariatric Surgery
    Lautenbach, Anne
    Wernecke, Marie
    Stoll, Fabian D.
    Meyhofer, Sebastian M.
    Meyhofer, Svenja
    Aberel, Jens
    DIABETES, 2022, 71
  • [40] Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    Aroda, Vanita
    Bain, Stephen
    Cariou, Bertrand
    Piletic, Milivoj
    Rose, Ludger
    Bergan, Eirik Quamme
    Zacho, Jeppe
    Devries, J. Hans
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S51 - S51
12345